People: Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

12:42am IST
Change (% chg)

$-0.02 (-1.07%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Firth, Carl 

Mr. Carl Firth (also named Yong Fu) has been serving as Chief Executive Officer and Director in ASLAN Pharmaceuticals Limited since July 26, 2019. He holds a Bachelor's degree in Natural Sciences and a Master's degree in Natural Sciences both from University of Cambridge, the United Kingdom, an Executive Master of Business Administration from London Business School, the United Kingdom, and a Ph.D. in Molecular Biology from University of Cambridge, the United Kingdom. He is also Independent Director in Uni-Bio Science Group Limited, Exploit Technologies Pte Ltd. and Hummingbird Biosciences, as well as Director in Kimba Capital Limited, Liberty Park Music Pte Ltd. and other three companies. He is also a Professor of Duke-NUS Graduate Medical School Singapore.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --